List of Speakers


2018 Conference Speakers

Jerel Banks, Chief Investment Officer, NantVentures
Paul BiondiSVP, Head of Business Development, Bristol-Myers Squibb
Kathy BowdishVice President Global R&D and Head of Sunrise Ventures, Sanofi U.S.
Dan Bradbury, Managing Member, BritBio, LLC
Paola Casarosa
Corporate Vice President Licensing, Boehringer Ingelheim
Hannah ChangInvestment Director, Wu Capital
Jon EdwardsPrincipal, Medicxi
Daniel Estes, Ph.D., Partner, Frazier Healthcare Partners
Chris HaskellVice President and Head, West Coast Innovation Center, Bayer
Richard HeymanTherapeutic Advisory Board, aTyr Pharma
Daria HazudaVice President of Infectious Diseases Discovery, Merck Research Laboratories
Natasha Hernday, Senior VP Corporate Development, Seattle Genetics
John Hood, Founder & CEO, Impact Biomedicines
David KabakoffExecutive Partner, Private Equity, Sofinnova Ventures
Balraj Kakkar, Partner and Managing Director, Ernst & Young LLP
Kim KamdarPartner, Domain Associates
Syed Kazmi, Executive Director, Business Development, Amgen
Chau KhuongPrivate Equity Partner, Orbimed
Tomas Landh, Innovation Sourcing Vice President, Senior Principal Scientist R&D External Innovation Sourcing, Novo Nordisk A/S Denmark
Ji LiExecutive Vice President, Global Head of Business Development, BeiGene
Bill Mendez, Vice President Alliance Management, BD Strategy & Operations, Pharma R&D, GSK
David MollerChief Scientific Officer, Sigilon Therapeutics
Ron NewboldSenior Vice President and Head of US Business Development & Alliance Management, Otsuka America Pharmaceuticals
Oleg Nodelman, Founder and Managing Director, EcoR1
Carole NuechterleinHead, Roche Venture Fund
Michael O’Donnell, Partner, Morrison Foerster 
Catherine Oyler, Global Head, Strategy & Operations, Johnson & Johnson External Innovation
Camille SamuelsPartner, Venrock 
Andy SchwabFounder and Managing Partner, 5AM Ventures
Armen Shanafelt, Ph.D., General Partner, Lilly Ventures
Jason Skolnik, Corporate and Securities Partner, Wilson Sonsini Goodrick & Rosati 
Bob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma, Pfizer Inc.
Avi SpierDirector, NIBR BD&L, Search and Evaluation, Novartis
Kumar SrinivasanVice President, Head of Scientific Partnering & Alliances, AstraZeneca
Darryl Steensma, Counsel, Latham & Watkins
Bruce SteelManaging Director, BioMed Ventures
Ben ThornerSenior Vice President and Head of Business Development & Licensing, Merck Ventures
Phil TinmouthVice President, Business Development & Alliance Management, Vertex Pharmaceuticals 
DA WallachRecording Artist and Songwriter Turned Investor
Jeff WarmkeSenior Vice President, External Scientific Affairs, Daiichi Sankyo